ASND
Ascendis Pharma·NASDAQ
--
--(--)
--
--(--)
5.60 / 10
Netural
Analyst sentiment is broadly positive (Strong Buy 25%, Buy 75%) with high conviction, yet historical win rates vary widely. Fund flows are robust (score 7.82/10) with consistent inflows across block and retail sizes, aligning with the optimistic analyst view and supporting near-term price momentum.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
25%
Buy
75%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-20
InstitutionWells Fargo
Times predicted3
Historical Win Rate100.0%
What is the analyst consensus for ASND?
- ASND holds a Bearish analyst rating, with 75% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.60/10 (Netural).
